A Multicenter, Open Phase IIb Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Colorectal Cancer
Clinical trial NCT06838546 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06838546
- Sponsor
- Tasly Biopharmaceuticals Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-24
- Primary completion
- 2027-01-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.